Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Multiple Myeloma 5 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Myelodysplastic Syndromes 4 Lung Neoplasms 4 Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Glioma 2 Colorectal Neoplasms 2 Osteosarcoma 1 Opioid-Related Disorders 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

pazopanib 3 Erlotinib Hydrochloride 3 Cetuximab 3 Vorinostat 2 Oxaliplatin 2 Bevacizumab 2 Azacitidine 2 satraplatin 1 ixazomib 1 X-Rays 1 Valproic Acid 1 Trastuzumab 1 Sorafenib 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Lenalidomide 1 Lapatinib 1 LY 2275796 1 Injections, Subcutaneous 1 Fluorouracil 1 Everolimus 1 Curcumin 1 Crizotinib 1 Capecitabine 1 Albumin-Bound Paclitaxel 1 AH 111585 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancers × X-Rays × Clear all

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡